Overexpression of miR-183 in HeLa cells has also been shown to inhibit migration and invasion, however this was shown to be mediated through direct targeting of integrin β1 (ITGB1)[30], indicating that miR-183 is likely to have a number of mRNA targets through which it mediates biological effects in cancer cells. Here, ITGB1 is linked to cancer.